CDK inhibitor NVP-LCQ195, Purity ≥98%

Synonym: 902156-99-4; LCQ-195; AT-9311; NVP LCQ195; LCQ 195; AT9311; AT 9311; CDK inhibitor

CAS Number: 902156-99-4
Compound CID: 11655534

Product Size

5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

NVP-LCQ195 is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk1/cyclin B, cdk2/cyclin A, CDK2/cyclinE, and CDK3/Cyclin E.

Molecular Weight

460.33

Molecular Formula

C₁₇H₁₉Cl₂N₅O₄S

Targets

Cdk1/cyclin B: 2 nM; cdk2/cyclin A: 2 nM; CDK2/cyclinE: 5 nM; CDK3/Cyclin E: 42 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

NVP-LCQ195 can be utilized to explore the inhibition of CDKs and potential applications in cancer therapy.